skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 83  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up
Material Type:
Article
Add to My Research

Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up

Therapeutics and clinical risk management, 2023-11, Vol.19, p.983-992 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S417426

Full text available

2
Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations
Material Type:
Article
Add to My Research

Vericiguat in Heart Failure with a Reduced Ejection Fraction: Patient Selection and Special Considerations

Therapeutics and clinical risk management, 2022-01, Vol.18, p.315-322 [Peer Reviewed Journal]

2022 Kassis-George et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Kassis-George et al. 2022 Kassis-George et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S357422 ;PMID: 35386181

Full text available

3
Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
Material Type:
Article
Add to My Research

Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date

Therapeutics and clinical risk management, 2020-01, Vol.16, p.681-688 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Akbar et al. 2020 Akbar et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S224772 ;PMID: 32801725

Full text available

4
Subclinical Hypothyroidism Predicted Adverse Cardiovascular Events in Patients with Ejection Fraction Preserved Heart Failure
Material Type:
Article
Add to My Research

Subclinical Hypothyroidism Predicted Adverse Cardiovascular Events in Patients with Ejection Fraction Preserved Heart Failure

Therapeutics and clinical risk management, 2024-01, Vol.20, p.227-237 [Peer Reviewed Journal]

2024 Tan et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S433489 ;PMID: 38706881

Full text available

5
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
Material Type:
Article
Add to My Research

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations

Therapeutics and clinical risk management, 2020-01, Vol.16, p.769-785 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Dzhioeva and Belyavskiy. 2020 Dzhioeva and Belyavskiy. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S207117 ;PMID: 32904123

Full text available

6
Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Prognostic role of copeptin with all-cause mortality after heart failure: a systematic review and meta-analysis

Therapeutics and clinical risk management, 2017-01, Vol.13, p.49-58 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Zhang et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S124689 ;PMID: 28115852

Full text available

7
Diagnosis and Screening of Patients with Fabry Disease
Material Type:
Article
Add to My Research

Diagnosis and Screening of Patients with Fabry Disease

Therapeutics and clinical risk management, 2020-01, Vol.16, p.551-558 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Vardarli et al. 2020 Vardarli et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S247814 ;PMID: 32606714

Full text available

8
Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital
Material Type:
Article
Add to My Research

Explorative analysis of gender-specific characteristics in patients with heart failure in an Italian hospital

Therapeutics and clinical risk management, 2019-07, Vol.15, p.847-850 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Perrone et al. 2019 Perrone et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S203011 ;PMID: 31360063

Full text available

9
Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Mortality and Readmission Rates After Heart Failure: A Systematic Review and Meta-Analysis

Therapeutics and clinical risk management, 2021-01, Vol.17, p.1307-1320 [Peer Reviewed Journal]

2021 Lan et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Lan et al. 2021 Lan et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S340587 ;PMID: 34908840

Full text available

10
New therapies for the treatment of heart failure: a summary of recent accomplishments
Material Type:
Article
Add to My Research

New therapies for the treatment of heart failure: a summary of recent accomplishments

Therapeutics and clinical risk management, 2019-01, Vol.15, p.147-155 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Machaj et al. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S179302 ;PMID: 30774351

Full text available

11
Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy
Material Type:
Article
Add to My Research

Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy

Therapeutics and Clinical Risk Management, 2023-01, Vol.19, p.133-142 [Peer Reviewed Journal]

2023 Colbert et al. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Colbert et al. 2023 Colbert et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S398163 ;PMID: 36756278

Full text available

12
Metastatic leiomyosarcoma presenting as a lung mass with left atrial extension: case report and anesthetic management
Material Type:
Article
Add to My Research

Metastatic leiomyosarcoma presenting as a lung mass with left atrial extension: case report and anesthetic management

Therapeutics and clinical risk management, 2018-01, Vol.14, p.141-147 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Qu et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S153484 ;PMID: 29403281

Full text available

13
Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review
Material Type:
Article
Add to My Research

Clinical Perspectives on Cardiac Rehabilitation After Heart Failure in Elderly Patients with Frailty: A Narrative Review

Therapeutics and clinical risk management, 2022-01, Vol.18, p.1009-1028 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Tsukakoshi et al. 2022 Tsukakoshi et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S350748

Full text available

14
Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
Material Type:
Article
Add to My Research

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality

Therapeutics and clinical risk management, 2017-01, Vol.13, p.1399-1407 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Rivinius et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S147062 ;PMID: 29075124

Full text available

15
Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives
Material Type:
Article
Add to My Research

Role of Finerenone in the Treatment of Diabetic Kidney Disease: Patient Selection and Clinical Perspectives

Therapeutics and clinical risk management, 2022-07, Vol.18, p.753-760 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Shaikh et al. 2022 Shaikh et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S325916 ;PMID: 35937973

Full text available

16
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
Material Type:
Article
Add to My Research

Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines

Therapeutics and clinical risk management, 2020-01, Vol.16, p.749-758 [Peer Reviewed Journal]

2020 Benson et al. ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Benson et al. 2020 Benson et al. ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S185677 ;PMID: 32884276

Full text available

17
Urinary cadmium levels predict mortality of patients with acute heart failure
Material Type:
Article
Add to My Research

Urinary cadmium levels predict mortality of patients with acute heart failure

Therapeutics and clinical risk management, 2017-01, Vol.13, p.379-386 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Hsu et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S119010 ;PMID: 28392700

Full text available

18
The limits of oral therapy in pulmonary arterial hypertension management
Material Type:
Article
Add to My Research

The limits of oral therapy in pulmonary arterial hypertension management

Therapeutics and clinical risk management, 2015-01, Vol.11 (default), p.1731-1741 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Liu and Jing. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1176-6336 ;ISSN: 1178-203X ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S49026 ;PMID: 26648729

Full text available

19
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
Material Type:
Article
Add to My Research

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data

Therapeutics and clinical risk management, 2020-01, Vol.16, p.715-726 [Peer Reviewed Journal]

2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Cuthbert et al. 2020 Cuthbert et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S234772 ;PMID: 32848403

Full text available

20
Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI
Material Type:
Article
Add to My Research

Comparison of Diagnostic Value Between STE+LDDSE and CMR-FT for Evaluating Coronary Microvascular Obstruction in Post-PCI Patients for STEMI

Therapeutics and clinical risk management, 2022-08, Vol.18, p.813-823 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Liu et al. 2022 Liu et al. ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S374866 ;PMID: 35996553

Full text available

Results 1 - 20 of 83  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait